Xortx Therapeutics Inc (XRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 11-2009 | 11-2008 | 11-2007 | 12-2006 | 11-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,935 | 28,013 | 70,678 | N/A | 56,921 |
| Receivables | 124,715 | 140,879 | 122,327 | N/A | 105,324 |
| Inventories | 108,625 | 128,183 | 91,662 | N/A | 93,111 |
| Income taxes - deferred | 405 | 1,000 | 3,000 | N/A | 2,513 |
| Other current assets | 5,825 | 4,430 | 8,275 | 0 | 7,247 |
| TOTAL | $296,289 | $305,251 | $298,936 | $N/A | $267,506 |
| Non-Current Assets | |||||
| PPE Net | 44,485 | 47,229 | 37,421 | N/A | 34,471 |
| Intangibles | 7,207 | 11,162 | 54,175 | 0 | 58,109 |
| Other Non-Current Assets | 6,269 | 9,545 | 19,743 | 0 | 15,594 |
| TOTAL | $57,961 | $67,936 | $111,339 | $N/A | $108,174 |
| Total Assets | $354,250 | $373,187 | $410,275 | $N/A | $375,680 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 104,966 | 121,040 | 109,326 | 0 | 101,541 |
| Other current liabilities | N/A | 13,266 | N/A | N/A | N/A |
| TOTAL | $135,012 | $159,598 | $137,014 | $N/A | $138,186 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 3,000 |
| Deferred Revenues | 10,620 | 8,386 | 15,212 | N/A | 16,303 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $3,000 |
| Total Liabilities | $135,012 | $159,598 | $137,014 | $N/A | $141,186 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,579 | 29,262 | 29,237 | N/A | 28,927 |
| Common Shares | 295 | 291 | 291 | N/A | 288 |
| Retained earnings | -155,580 | -139,166 | -85,145 | N/A | -113,254 |
| Other shareholders' equity | 3,598 | -13,603 | 1,847 | 0 | 2,774 |
| TOTAL | $219,238 | $213,589 | $273,261 | $N/A | $234,494 |
| Total Liabilities And Equity | $354,250 | $373,187 | $410,275 | $0 | $375,680 |